J
Jianmin Wang
Researcher at Second Military Medical University
Publications - 154
Citations - 3040
Jianmin Wang is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 25, co-authored 148 publications receiving 2386 citations. Previous affiliations of Jianmin Wang include China Medical University (PRC).
Papers
More filters
Journal ArticleDOI
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang,Zhaohui Gu,Zi-Xun Yan,Xia Zhao,Yin-Yin Xie,Zi-Guan Zhang,Chun-Ming Pan,Yuan Hu,Chang-Ping Cai,Ying Dong,Jinyan Huang,Li Wang,Yang Shen,Guoyu Meng,Jianfeng Zhou,Jianda Hu,Jin-Fen Wang,Yuan-Hua Liu,Lin-Hua Yang,Feng Zhang,Jianmin Wang,Zhao Wang,Zhigang Peng,Fang-Yuan Chen,Zi-Min Sun,Hao Ding,Jumei Shi,Jian Hou,Jin-Song Yan,Jing-Yi Shi,Lan Xu,Yang Li,Jing Lu,Zhong Zheng,Wen Xue,Wei-Li Zhao,Zhu Chen,Sai-Juan Chen +37 more
TL;DR: This work identified somatic gene mutations in 25 people with NKTCL by whole-exome sequencing and confirmed them in an extended validation group of 80 people by targeted sequencing, contributing to the understanding of the disease mechanism ofNKTCL.
Journal ArticleDOI
Identification of functional cooperative mutations of SETD2 in human acute leukemia
Xiaofan Zhu,Fuhong He,Hui-Min Zeng,Shaoping Ling,Aili Chen,Ya-Qin Wang,Xiaomei Yan,Wei Wei,Yakun Pang,Hui Cheng,Chunlan Hua,Yue Zhang,Xuejing Yang,Xin Lu,Lihua Cao,Lingtong Hao,Lili Dong,Wei Zou,Jun Wu,Xia Li,Si Zheng,Jin Yan,Jing Zhou,Lixia Zhang,Shuangli Mi,Xiaojuan Wang,Li Zhang,Yao Zou,Yumei Chen,Zhe Geng,Jianmin Wang,Jianfeng Zhou,Xin Liu,Jianxiang Wang,Weiping Yuan,Gang Huang,Tao Cheng,Qianfei Wang +37 more
TL;DR: This study provides compelling evidence for SETD2 as a new tumor suppressor by identifying a transforming MLL-NRIP3 fusion gene and biallelic mutations inSETD2 (encoding a histone H3K36 methyltransferase), which is a distinct epigenetic mechanism for leukemia development.
Journal ArticleDOI
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology
Lan-Ping Xu,Hu Chen,Jing Chen,Mingzhe Han,He Huang,Yongrong Lai,Dai-Hong Liu,Qifa Liu,Ting Liu,Ming Jiang,Hanyun Ren,Yongping Song,Zimin Sun,Jianmin Wang,Depei Wu,Daobin Zhou,Ping Zou,Kai-Yan Liu,Xiao-Jun Huang,Xiao-Jun Huang +19 more
TL;DR: The consensus on routine practices of all-HSCT in China is summarized and the recommendations of indications, conditioning regimen, and donor selection are focused on.
Journal ArticleDOI
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
Lan-Ping Xu,Song Jin,Shunqing Wang,Linghui Xia,Hai Bai,Sujun Gao,Qifa Liu,Jianmin Wang,Xin Wang,Ming Jiang,Xi Zhang,Depei Wu,Xiao-Jun Huang,Xiao-Jun Huang +13 more
TL;DR: Haploidentical SCT as upfront therapy was an effective and safe option for SAA patients, with favorable outcomes in experienced centers, and survival outcome for the entire population was significantly adversely associated with increased transfusions and poor performance status pre-SCT.
Journal ArticleDOI
Homoharringtonine and omacetaxine for myeloid hematological malignancies
Shuqing Lü,Jianmin Wang +1 more
TL;DR: This review summarized preclinical and clinical development of HHT and omacetaxine for myeloid hematological malignancies.